TABLE 2.

Characteristics of the study participants by tertiles of fasting triglyceride concentrations¹

	Tertiles of plasma triglyceride levels
	1 (Low)	2	3 (High)	P
n	68	70	70
Age, y	33.2 ± 7.5	34.6 ± 7.8	34.3 ± 7.0	0.46
Gender, % women	47	60	56	0.31
BMI, kg/m2	20.00 ± 2.69	20.39 ± 2.74	19.74 ± 2.53	0.33
Waist circumference, cm	71.92 ± 6.02	73.05 ± 7.10	72.66 ± 5.98	0.70
Mid-upper arm circumference, cm	24.89 ± 2.72	25.40 ± 2.70	24.25 ± 2.54	0.06
Current smokers, n (%)	2(3.1)	5 (7.1)	4 (6.1)	0.63
Current alcohol use, n (%)	8 (12.3)	11 (15.7)	3 (4.6)	0.09
Fasting plasma insulin, mU/L	3.81 ± 3.37	4.62 ± 6.42	5.84 ± 6.94	0.30
Fasting blood glucose, mmol/L	3.67 ± 0.70	3.73 ± 0.61	3.98 ± 1.61	0.25
CD4 count, cells/μl	131 ±48	152 ± 59	130 ± 47	0.08
Triglycerides, mmol/L	0.74 ±0.15	1.08 ±0.11	1.88±0.62	N/A
Total cholesterol, mmol/L	3.24 ±0.90	3.48 ± 0.90	3.63 ± 0.95	0.06
LDL-cholesterol, mmol/L	1.98 ±0.58	2.10 ± 0.78	1.90 ± 0.89	0.18
HDL-cholesterol, mmol/L	0.95 ±0.47	0.89 ± 0.52	0.58 ± 0.35	<0.0001
Total cholesterol : HDL ratio	4.82 ± 4.89	5.79 ± 5.75	22.74 ± 63.37	<0.0001
Dietary variables
Total energy, kJ/d	7713 ± 2642	7266 ± 3194	6947 ± 2870	0.18
Carbohydrate, % energy/d	56.59 ± 13.24	53.84 ±13.56	57.87 ± 13.02	0.32
Protein, % energy/d	13.28 ± 3.94	13.60 ± 4.34	12.53 ± 4.13	0.19
Total fat, % energy/d	30.51 ± 11.12	33.14 ±11.78	30.78 ± 11.01	0.66
Saturated fat, % energy/d	6.41 ± 2.53	6.54 ±3.12	5.99 ± 2.42	0.51
Monounsaturated fat, % energy/d	9.03 ± 3.93	9.47 ±3.57	8.74 ± 3.64	0.66
Polyunsaturated fat, , % energy/d	12.77 ± 5.78	14.63 ± 6.65	13.81 ± 5.77	0.35
Trans fat, % energy/d	0.56 ± 0.71	0.46 ± 0.68	0.48 ± 0.77	0.25
n3 Fatty acids, % energy/d	1.74 ± 0.98	1.86 ± 1.03	1.75 ± 0.94	0.80
Common HAART regimen, n (%)
Zidovudine,+Lamivudine+ Nevirapine	30 (48.4)	26 (39.4)	23 (37.1)	0.17
Stavudine+Lamivudine+ Nevirapine	14 (22.6)	22 (33.3)	27 (43.6)
Tenofovir+Emtricitabine+Nevirapine	18 (29.0)	18 (27.3)	12 (19.4)

¹Values are means ± SD or percentages.